-transparent.png){kind=logo}
Failure of intravenously administered [99mTc] pertechnetate to leave the vascular space was observed in a patient with hyperaluminemia due to treatment with an antacid drug containing aluminum hydroxide. A repeat study 3 mo after discontinuing medication, when the plasma aluminum level had fallen, revealed normal in vivo distribution of pertechnetate. It was found that instant thin-layer chromatography, using pertechnetate and an 85% methanol system, can detect plasma aluminum levels as low as 50 microgram/l.
Related Publications
T S Wang, and
R A Fawwaz, and
P D Esser, and
P M Johnson
July 1979,
Clinical nuclear medicine,
T S Wang, and
R A Fawwaz, and
P D Esser, and
P M Johnson
April 1977,
Radiology,
T S Wang, and
R A Fawwaz, and
P D Esser, and
P M Johnson
June 1980,
Biulleten' eksperimental'noi biologii i meditsiny,
T S Wang, and
R A Fawwaz, and
P D Esser, and
P M Johnson
January 1975,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
T S Wang, and
R A Fawwaz, and
P D Esser, and
P M Johnson
March 1974,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
T S Wang, and
R A Fawwaz, and
P D Esser, and
P M Johnson
January 1976,
International journal of nuclear medicine and biology,
T S Wang, and
R A Fawwaz, and
P D Esser, and
P M Johnson
April 1974,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
T S Wang, and
R A Fawwaz, and
P D Esser, and
P M Johnson
February 1977,
Nuklearmedizin. Nuclear medicine,
T S Wang, and
R A Fawwaz, and
P D Esser, and
P M Johnson
August 1977,
Radiology,
T S Wang, and
R A Fawwaz, and
P D Esser, and
P M Johnson
October 1993,
International journal of radiation biology,
